Targeting Senescence as a Therapeutic Opportunity for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is associated with an elevated risk of recurrence and poor prognosis. Historically, only chemotherapy was available as systemic treatment, but immunotherapy and targeted therapies currently offer prolonged benefits. TNBC is a group of diseases with heterogeneous...

Descripción completa

Detalles Bibliográficos
Autores principales: de Paula, Bruno, Kieran, Rosalind, Koh, Samantha Shui Yuan, Crocamo, Susanne, Abdelhay, Eliana, Muñoz-Espín, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Cancer Hallmarks Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157365/
https://www.ncbi.nlm.nih.gov/pubmed/36752780
http://dx.doi.org/10.1158/1535-7163.MCT-22-0643

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10157365/
https://www.ncbi.nlm.nih.gov/pubmed/36752780
http://dx.doi.org/10.1158/1535-7163.MCT-22-0643

Ejemplares similares